Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

WFDC5 Inhibitors

WFDC5 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the WFDC5 protein, which belongs to the whey acidic protein (WAP) domain family. The WFDC5 protein contains the characteristic WAP domain, a conserved structure known for its role in the regulation of protease activity, particularly serine proteases. Serine proteases are involved in various biological processes such as immune responses, tissue remodeling, and cellular signaling. WFDC5, like other members of the WAP family, is thought to function as a protease inhibitor, playing a key role in controlling proteolytic activity within different physiological contexts. Inhibiting WFDC5 impacts its ability to regulate protease interactions, potentially altering pathways involved in maintaining cellular homeostasis and structural integrity.

The molecular mechanism of WFDC5 inhibitors typically involves the binding of the inhibitor to the WAP domain or other critical regions of the WFDC5 protein, thereby preventing it from interacting with and inhibiting specific target proteases. This disruption leads to changes in protease activity, affecting processes such as extracellular matrix degradation, immune cell function, and tissue organization. Researchers utilize WFDC5 inhibitors to study the specific role of this protein in protease regulation and to investigate its broader influence on cellular and molecular systems. By selectively inhibiting WFDC5, these compounds offer valuable insights into the complex regulatory networks of proteolysis, allowing scientists to better understand the biological importance of WAP domain-containing proteins in maintaining protease balance and their involvement in various cellular functions.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, impacting various cellular processes that might intersect with WFDC5's function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A phosphoinositide 3-kinases (PI3K) inhibitor, potentially altering cellular signaling pathways affecting WFDC5.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

A MEK inhibitor, potentially affecting the ERK/MAPK pathway, which could indirectly influence WFDC5 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

Inhibits p38 MAP kinase, possibly altering signaling pathways relevant to WFDC5's function.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

A JNK inhibitor, potentially modifying signaling pathways indirectly affecting WFDC5.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Inhibits V-ATPase, potentially impacting endosomal-lysosomal functioning, influencing WFDC5 indirectly.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Known to affect autophagy and lysosomal function, which might indirectly influence WFDC5.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$56.00
$256.00
113
(3)

An autophagy inhibitor, potentially impacting WFDC5 indirectly.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A potent PI3K inhibitor, potentially affecting WFDC5 activity through intracellular signaling pathways.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

A ROCK inhibitor, potentially influencing cytoskeletal dynamics relevant to WFDC5's function.